Browse our news and publications or find information on upcoming events in the Schizophrenia Program.
07/15/2014: #1 in New England, #2 in the nation
U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.
01/07/2014: Longer-term varenicline treatment improves tobacco abstinence for people with serious mental illness
Extended treatment with the smoking cessation drug varenicline significantly improved the ability of individuals with serious mental illness to maintain abstinence from tobacco after a standard 12-week course of treatment.
A new study published in the May issue of the American Journal of Preventive Medicine finds that Google searches for information across all major mental illnesses and problems followed seasonal patterns, suggesting mental illness may be more strongly linked with seasonal patterns than previously thought.
03/06/2013: Folate and vitamin B12 supplementation reduces disabling schizophrenia symptoms in patients with specific gene variants
Adding the dietary supplements folate and vitamin B12 to treatment with antipsychotic medication improved a core symptom component of schizophrenia in a study of more than 100 patients.
04/03/2011: Antipsychotics and the Shrinking Brain
Dr. Donald C. Goff discusses, in an article for the Psychiatric Times, previous findings published in the February 2011 issue of the Archives of General Psychiatry that examined the relationship between long-term antipsychotic treatment and brain volume in first-episode schizophrenia patients.
09/10/2010: The Latest in Schizophrenia Treatment
Dr. Donald C. Goff writes about the latest findings in the treatment for schizophrenia. The article was published in the Fall 2010 edition of the NAMI Advocate.
09/06/2010: Getting ahead of trouble
The First-Episode and Early Psychosis Program (FEPP) at Massachusetts General Hospital made the news recently, as the benefits of their early detection and treatment program were recognized.
02/03/2007: Cognitive Behavioral Therapy (CBT) for Schizophrenia - An Indepth Interview with Experts
During the past year Schizophrenia.com has covered the increasing number of positive research reports on the use of cognitive behavioral therapy (CBT) as a new complementary treatment for schizophrenia. Dr. Gottlieb and Dr. Cather of Massachusetts General Hospital were interviewed to help our readers better understand the positive effects of CBT.
06/27/2014: Mindscapes Summer 2014
View the Mindscapes Summer 2014 newsletter
Dr. Joshua Roffman’s research and recent awards are highlighted in faculty news.
08/29/2013: Mindscapes Summer 2013
View the Mindscapes Summer 2013 newsletter (PDF)
Elissa Freud and Steve Willis Help Advance Research in Bipolar Disorder and Schizophrenia.
01/23/2013: Mindscapes Winter 2013
View the Mindscapes Winter 2013 issue (PDF)
The Inaugural Donald C. Goff, MD Lecture in Schizophrenia is highlighted.
08/21/2012: Mindscapes Summer 2012
View the Mindscapes Summer 2012 issue (PDF)
Dr. David Henderson Named Schizophrenia Program Director.
10/10/2010: Mindscapes Fall 2010
Treating genetic deficit linked to negative symptoms in schizophrenia
Dr. Josh Roffman contributes with an article which discusses using nutritional supplements to improve treatment of patients with schizophrenia.
11/09/2013: 11th Annual Schizophrenia Education Day
A free educational program for patients, families, and friends on how recent advances in treatment can help improve the lives of patients and their families
11/10/2012: 10th Annual Schizophrenia Education Day
A free educational program for patients, families, and friends reviewing the progress made in the care of patients.
David and Adam talk about their experiences in finding the right medication.
Hear from all three guest speakers as they talk about advice for family members.
David, Jonathan and Adam discuss their experiences in dealing with ongoing symptoms.
Adam answers the question about experiencing suicidal thoughts.
Hear from all three guest speakers as they talk about how they made the decision to take medication .
Schizophrenia: What are some of the barriers to accessing treatment that people with schizophrenia face?
David talks about not having many options for treatment.